Pulmonary Complications of Sickle Cell Disease

REFERENCES

• Cavalli-Sforza LL, Menozzi P, Piazza A, Eds. The History and Geography of Human Genes. Princeton: Princeton University Press, 1994.
   Google Scholar
• Aliyu ZY, Gordeuk V, Sachdev V, . Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. Am J Hematol. 2008;83(6):485–490.
   PubMed Web of Science ®Google Scholar
• Noguchi CT, Schechter AN, Rodgers GP. Sickle cell disease pathophysiology. Bailliére’s Clin Haematol. 1993;6(1):57–91.
   PubMedGoogle Scholar
• Bailey K, Morris JS, Thomas P, Serjeant JR. Fetal haemoglobin and early manifestations of homozygous sickle cell disease. Arch Dis Child. 1992;67(4):517–520.
   PubMed Web of Science ®Google Scholar
• Castro O, Brambilla DJ, Thorington B, . The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood. 1994;84(2):643–649.
   Google Scholar
• Charache S, Scott JC, Charache P. “Acute chest syndrome” in adults with sickle cell anemia. Microbiology, treatment, and prevention. Arch Intern Med. 1979;139(1):67–69.
   Google Scholar
• Vichinsky EP, Neumayr LD, Earles AN, . Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342(25):1855–1865.
   PubMed Web of Science ®Google Scholar
• Vichinsky EP, Styles LA, Colangelo LH, . Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood. 1997;89(5):1787–1792.
   Google Scholar
• Barrett-Connor E. Acute pulmonary disease and sickle cell anemia. Am Rev Respir Dis. 1971;104(2):159–165.
   PubMed Web of Science ®Google Scholar
• Barrett-Connor, E. Pneumonia and pulmonary infarction in sickle cell anemia. JAMA. 1973;224(7):997–1000.
   PubMed Web of Science ®Google Scholar
• Tsolia MN, Psarras S, Bossios A, . Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis. 2004;39(5):681–686.
   PubMed Web of Science ®Google Scholar
• Apisarnthanarak A, Mundy LM. Etiology of community-acquired pneumonia. Clin Chest Med. 2005;26(1):47–55.
   PubMed Web of Science ®Google Scholar
• Vichinsky EP, Williams R, Das M, . Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood. 1994;83(11):3107–3112.
   PubMed Web of Science ®Google Scholar
• Styles LA, Aarsman AJ, Vichinsky EP, Kuypers FA. Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood. 2000;96(9):3276–3278.
   PubMed Web of Science ®Google Scholar
• Ballas SK, Files SB, Luchtman-Jones L, . Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin. 2006;30(2):165–170.
   PubMed Web of Science ®Google Scholar
• Styles LA, Abboud M, Larkin S, . Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol. 2007;136(2):343–344.
   PubMed Web of Science ®Google Scholar
• Abboud MR, Taylor EC, Habib D, . Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte stimulating factor asociated with the acute chest syndrome in sickle cell disease. Br J Hematol. 2000;111(2):482–490.
   PubMed Web of Science ®Google Scholar
• Bellet PS, Kalinyak KA, Shukla R, . Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med. 1995;333(11):699–703.
   PubMed Web of Science ®Google Scholar
• Charache S, Terrin ML, Moore RD, . Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332(20):1317–1322.
   PubMed Web of Science ®Google Scholar
• Wang WC, Ware RE, Miller ST, . Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377(9778):1663–1672.
   PubMed Web of Science ®Google Scholar
• Bernini JC, Rogers ZR, Sandler ES, . Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood. 1998;92(9):3082–3089.
   PubMed Web of Science ®Google Scholar
• Sobota A, Graham DA, Heeney MM, Neufeld EJ. Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission. Am J Hematol. 2010;85(1):24–28.
   PubMed Web of Science ®Google Scholar
• Strouse JJ, Takemoto CM, Keefer JR, . Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatr Blood Cancer. 2008;50(5):1006–1012.
   PubMed Web of Science ®Google Scholar
• Reagan MM, DeBaun MR, Frei-Jones MJ. Multi-modal intervention for the inpatient management of sickle cell pain significantly decreases the rate of acute chest syndrome. Pediatr Blood Cancer. 2011;56(2):262–266.
   PubMed Web of Science ®Google Scholar
• Miller ST, Wright E, Abboud M, . Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr. 2001;139(6):785–789.
   PubMed Web of Science ®Google Scholar
• Hankins J, Jeng M, Harris S, . Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome. J Pediatr Hematol Oncol. 2005;27(3):158–161.
   PubMed Web of Science ®Google Scholar
• Collins FS, Orringer EP. Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies. Am J Med. 1982;73(6):814–821.
   PubMed Web of Science ®Google Scholar
• Hayag-Barin JE, Smith RE, Tucker FC Jr. Hereditary spherocytosis, thrombocytosis, and chronic pulmonary emboli: a case report and review of the literature. Am J Hematol. 1998;57(1):82–84.
   PubMed Web of Science ®Google Scholar
• Aeossopos A, Farmakis D, Karagiorga M, . Cardiac involvement in thalassemia intermedia: a multicenter study. Blood. 2001;97(11):3411–3416.
   PubMed Web of Science ®Google Scholar
• Castro O, Hoque M, Brown BD. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood. 2003;101(4):1257–1261.
   PubMed Web of Science ®Google Scholar
• Gladwin MT, Sachdev V, Jison ML, . Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350(9):886–895.
   PubMed Web of Science ®Google Scholar
• Ataga KI, Sood N, De Gent G, . Pulmonary hypertension in sickle cell disease. Am J Med. 2004;117(9):665–669.
   PubMed Web of Science ®Google Scholar
• Sutton LL, Castro O, Cros DJ, . Pulmonary hypertension in sickle cell disease. Am J Cardiol. 1994;74(6):626–628.
   PubMed Web of Science ®Google Scholar
• Dahoui HA, Hayek MN, Nietert PJ, . Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering. Pediatr Blood Cancer. 2010;54(3):398–402.
   PubMed Web of Science ®Google Scholar
• Minniti CP, Sable C, Campbell A, . Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica. 2009;94(3):340–347.
   PubMed Web of Science ®Google Scholar
• Gordeuk VR, Minniti CP, Nouraie M, . Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia. Haematologica. 2011;96(1):33–40.
   PubMed Web of Science ®Google Scholar
• Parent F, Bachir D, Inamo J, . A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med. 2011;365(1):44–53.
   PubMed Web of Science ®Google Scholar
• De Castro LM, Jonassaint JC, Graham FL, . Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am J Hematol. 2008;83(1):19–25.
   PubMed Web of Science ®Google Scholar
• Ataga KI, Moore CG, Jones S, . Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol. 2006;134(1):109–115.
   PubMed Web of Science ®Google Scholar
• Morris CR, Kato GJ, Poljakovic M, . Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005;294(1):81–90.
   PubMed Web of Science ®Google Scholar
• Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293(13):1653–1662.
   PubMed Web of Science ®Google Scholar
• Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21(1):37–47.
   PubMed Web of Science ®Google Scholar
• Machado RF, Gladwin MT. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Br J Haematol. 2005;129(4):449–464.
   PubMed Web of Science ®Google Scholar
• Morris CR, Galdwin MT, Kato GJ. Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders. Curr Mol Med. 2008;8(7):620–632.
   PubMed Web of Science ®Google Scholar
• Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med. 2008;359(21):2254–2265.
   PubMed Web of Science ®Google Scholar
• Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT. Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol. 2009;84(9):618–625.
   PubMedGoogle Scholar
• Galie N, Manes A, Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res. 2004;61(2):227–237.
   PubMed Web of Science ®Google Scholar
• Graido-Gonzalez E, Doherty JC, Bergreen EW, . Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood. 1998;92(7):2551–2555.
   PubMed Web of Science ®Google Scholar
• Werdehoff SG, Moore RB, Hoff CJ, . Elevated plasma endothelin-1 levels in sickle cell anemia: relationships to oxygen saturation and left ventricular hypertrophy. Am J Hematol. 1998;58(3):195–199.
   PubMed Web of Science ®Google Scholar
• Bunn HF, Nathan DG, Dover GJ, . Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood. 2010;116(5):687–692.
   PubMed Web of Science ®Google Scholar
• Machado RF, Barst RJ, Yovetich NA, . Safety and efficacy of sildenafil therapy for doppler-defined pulmonary hypertension in patients with sickle cell disease: Preliminary results of the WALK PHaSST Clinical Trial (Proceedings of the 51st American Society of Hematology). Blood. 2009;114(22): (Abstract 571).
   PubMed Web of Science ®Google Scholar
• Minniti CP, Machado RF, Coles WA, . Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease. Br J Haematol. 2009;147(5):737–743.
   PubMed Web of Science ®Google Scholar
• Boyd JH, Macklin EA, Strunk RC, DeBaun MR. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood. 2006;108(9):2923–2927.
   PubMed Web of Science ®Google Scholar
• Bryant R. Asthma in the pediatric sickle cell patient with acute chest syndrome. J Pediatr Health Care. 2005;19(3):157–162.
   PubMedGoogle Scholar
• Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax. 2005;60(3):206–210.
   PubMed Web of Science ®Google Scholar
• An P, Barron-Casella EA, Strunk RC, . Elevation of IgE in children with sickle cell disease is associated with doctor diagnosis of asthma and increased morbidity. J Allergy Clin Immunol. 2011;127(6):1440–1446.
   PubMed Web of Science ®Google Scholar
• Bernaudin F, Strunk RC, Kamdem A, . Asthma is associated with acute chest syndrome, but not with an increased rate of hospitalization for pain among children in France with sickle cell anemia: a retrospective cohort study. Haematologica. 2008;93(12):1917–1918.
   PubMed Web of Science ®Google Scholar
• Boyd JH, Macklin EA, Strunk RC, DeBaun MR. Asthma is associated with increased mortality in individuals with sickle cell anemia. Haematologica 2007;92(8):1115–8.
   PubMed Web of Science ®Google Scholar
• Field JJ, DeBaun MR. Asthma and sickle cell disease: two distinct diseases or part of the same process? Hematology Am Soc Hematol Educ Program. 2009:45–53.
   Google Scholar
• Klings ES, Wyszynski DF, Nolen VG, Steinberg MH. Abnormal pulmonary function in adults with sickle cell anemia. Am J Respir Crit Care Med. 2006;173(11):1264–1269.
   PubMed Web of Science ®Google Scholar
• Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. The impact of recurrent acute chest syndrome on the lung function of young adults with sickle cell disease. Lung. 2010;188(6):499–504.
   PubMed Web of Science ®Google Scholar
• Koumbourlis AC, Lee DJ, Lee A. Longitudinal changes in lung function and somatic growth in children with sickle cell disease. Pediatr Pulmonol. 2007;42(6):483–488.
   PubMed Web of Science ®Google Scholar
• Koumbourlis AC, Hurlet-Jensen A, Bye MR. Lung function in infants with sickle cell disease. Pediatr Pulmonol. 1997;24(4):277–281.
   PubMed Web of Science ®Google Scholar
• Hijazi Z, Onadeko BO, Khadadah M, . Pulmonary function studies in children with sickle cell disease and elevated Hb F. Int J Clin Pract. 2005;59(2):163–167.
   PubMed Web of Science ®Google Scholar